(1.03%) 5 180.74 points
(0.46%) 38 852 points
(1.19%) 16 349 points
(0.33%) $78.74
(0.27%) $2.20
(0.18%) $2 335.40
(0.29%) $27.70
(0.26%) $967.40
(0.02%) $0.928
(0.04%) $10.83
(0.01%) $0.796
(-0.11%) $91.35
2 days till quarter result
(bmo 2024-05-08)
Expected move: +/- 15.84%
-4.62% $ 2.89
Live Chart Being Loaded With Signals
Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases...
Stats | |
---|---|
Dzisiejszy wolumen | 74 867.00 |
Średni wolumen | 86 385.00 |
Kapitalizacja rynkowa | 108.62M |
EPS | $0 ( 2024-03-26 ) |
Następna data zysków | ( $-0.600 ) 2024-05-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.360 |
ATR14 | $0.0180 (0.63%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-18 | Kaufmann Petra | Buy | 330 000 | Stock Option Grant (Right to Buy) |
2024-03-18 | Kaufmann Petra | Buy | 0 | |
2024-03-01 | Booth Bruce | Buy | 34 612 | Stock Option Grant (Right to Buy) |
2024-03-01 | Bruhn Suzanne Louise | Buy | 24 073 | Stock Option Grant (Right to Buy) |
2024-03-01 | Blanchard Cheryl R | Buy | 24 761 | Stock Option Grant (Right to Buy) |
INSIDER POWER |
---|
99.98 |
Last 93 transactions |
Buy: 32 103 135 | Sell: 31 582 660 |
Wolumen Korelacja
Vigil Neuroscience, Inc. Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
RMRM | 0.816 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Vigil Neuroscience, Inc. Korelacja - Waluta/Towar
Vigil Neuroscience, Inc. Finanse
Annual | 2023 |
Przychody: | $0 |
Zysk brutto: | $-399 000 (0.00 %) |
EPS: | $-2.13 |
FY | 2023 |
Przychody: | $0 |
Zysk brutto: | $-399 000 (0.00 %) |
EPS: | $-2.13 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $-1.01M (0.00 %) |
EPS: | $-2.14 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-1.531 |
Financial Reports:
No articles found.
Vigil Neuroscience, Inc.
Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed on myeloid cells 2 (TREM2) which is in Phase I for the treatment of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia, as well as for the treatment of cerebral adrenoleukodystrophy and alzheimer's disease. The company also develops a small molecule TREM2 agonist suitable for oral delivery to treat common neurodegenerative diseases associated with microglial dysfunction. Vigil Neuroscience, Inc. was incorporated in 2020 and is headquartered in Cambridge, Massachusetts.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej